All News #Library
Rare Diseases
Plus Therapeutics Updates REYOBIQ Program, CNSide U.S. Launch
22 Jan 2026 //
GLOBENEWSWIRE
Plus Therapeutics Starts Trial for Leptomeningeal Metastases
08 Jul 2025 //
GLOBENEWSWIRE
Plus Therapeutics` Reyobiq Shows Benefit in ReSPECT-LM Trial
14 May 2025 //
GLOBENEWSWIRE
Plus Therapeutics Gets FDA Orphan Drug Nod For Rhenium-186 In Lung Mets
06 Mar 2025 //
GLOBENEWSWIRE
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium Obisbemeda
03 Nov 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support